Home Cell Cycle RUNX activator Muramyl dipeptide (MDP) For research use only.

Muramyl dipeptide (MDP)

Muramyl dipeptide (MDP) is a shared structural unit of peptidoglycans. Muramyl dipeptide is an inducer of bone formation through the induction of Runx2.

Muramyl dipeptide (MDP) Chemical Structure

Muramyl dipeptide (MDP) Chemical Structure

CAS No. 53678-77-6

Purity & Quality Control

Muramyl dipeptide (MDP) Related Products

Biological Activity

Description Muramyl dipeptide (MDP) is a shared structural unit of peptidoglycans. Muramyl dipeptide is an inducer of bone formation through the induction of Runx2.
Targets
Runx2 [1]
In vitro
In vitro

MDP directly augments osteoblast differentiation and bone-forming gene expression by Runx2 activation. Despite no direct effect, MDP indirectly attenuates osteoclast differentiation through down-regulation of the RANKL/OPG ratio. MDP increases the expression of the MDP receptor, Nod2, and MDP-induced bone formation and osteoblast activation does not occur during Nod2-deficiency.[1]
Cell Research Cell lines MC3T3-E1 cells, BMSCs, or primary osteoblast precursors from mouse calvaria
Concentrations 0.1 μg/ml, 1 μg/ml, 10 μg/ml
Incubation Time 2 days
Method

MC3T3-E1 cells, BMSCs, or primary osteoblast precursors from mouse calvaria are plated onto 48-well plates at 2×104 cells/400 μl/well and incubated with osteoblast induction medium in the absence or presence of MDP. Half of the medium is replaced with fresh osteoblast induction medium every 2 days. At day 6 and 12, the cells are stained with ALP for osteoblast differentiation and with alizarin red S for bone mineralization, respectively.
In Vivo
In vivo

Increased bone and mineral density by enhanced bone formation are observed in mice administered with Muramyl dipeptide (MDP). Remarkably, pre-treatment or post-treatment with MDP alleviates bone loss in RANKL-induced osteoporosis mouse models.[1]
Animal Research Animal Models Five-week-old C57BL/6 mice, one-day-old neonatal mice, B6.129S1-Nod2tm1Flv/J mice
Dosages 1.25 mg/kg
Administration IP
NCT Number Recruitment Conditions Sponsor/Collaborators Start Date Phases
NCT06079567 Recruiting
Facioscapulohumeral Muscular Dystrophy Type 2
Centre Hospitalier Universitaire de Nice
 October 3 2023 Not Applicable
NCT06045338 Not yet recruiting
Long COVID|Post-Acute Sequelae of COVID-19|COVID Long-Haul
Beth Israel Deaconess Medical Center
 October 2023 Not Applicable
NCT06110403 Recruiting
Copd
University Hospital Lille|AstraZeneca
 September 29 2023 Phase 1|Phase 2
NCT06012006 Not yet recruiting
COPD
Assistance Publique - Hôpitaux de Paris
 August 2023 Not Applicable

Chemical Information & Solubility

Molecular Weight 492.48 Formula

C19H32N4O11
CAS No. 53678-77-6 SDF --
Smiles CC(NC(=O)C(C)OC1C(O)C(CO)OC(O)C1NC(C)=O)C(=O)NC(CCC(O)=O)C(N)=O
Storage (From the date of receipt) 3 years -20°C powder

In vitro
Batch:

DMSO : 98 mg/mL ( (198.99 mM) Moisture-absorbing DMSO reduces solubility. Please use fresh DMSO.)

Water : 98 mg/mL

Ethanol : Insoluble


Molecular Weight Calculator

In vivo
Batch:

Add solvents to the product individually and in order.


In vivo Formulation Calculator

Preparing Stock Solutions

Molarity Calculator

Mass Concentration Volume Molecular Weight

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg g μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO % % Tween 80 % ddH2O
%DMSO %

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Muramyl dipeptide (MDP) | Muramyl dipeptide (MDP) supplier | purchase Muramyl dipeptide (MDP) | Muramyl dipeptide (MDP) cost | Muramyl dipeptide (MDP) manufacturer | order Muramyl dipeptide (MDP) | Muramyl dipeptide (MDP) distributor